Researchers are Testing a Drug That May Slow the Progression of Parkinson’s Disease
According to a recent article in Parkinson’s News Today, the drug prasinezumab has entered the second half of a Phase 2 trial. An earlier trial, NCT02157714, showed that the therapy…